Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BIOFRONTERA AG

(B8F)
  Report
Delayed Xetra  -  11:36 2022-12-09 am EST
1.580 EUR    0.00%
12/08Biofrontera AG Announces Executive Appointments to Biofrontera UK Ltd
CI
12/08Biofrontera AG Establishes UK Subsidiary to Strengthen Its Sales Activities in the Country
CI
11/23Biofrontera AG Continues to Adhere to Its Forecast for Fiscal Year 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 



Copyright ę 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ôInformationö) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,58 €
Average target price 2,80 €
Spread / Average Target 77,2%
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
BIOFRONTERA AG11.74%94
CSL LIMITED2.33%96 965
SAMSUNG BIOLOGICS CO.,LTD.-8.42%44 692
BIOGEN INC.20.50%41 631
WUXI BIOLOGICS (CAYMAN) INC.-39.98%30 132
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-30.36%19 486